S&P 500 Futures
(-0.24%) 5 240.50 points

Dow Jones Futures
(-0.04%) 38 216 points

Nasdaq Futures
(-0.47%) 18 520 points

Oil
(-0.21%) $77.75

Gas
(-0.70%) $2.55

Gold
(-0.12%) $2 363.70

Silver
(-0.77%) $31.29

Platinum
(-0.66%) $1 031.20

USD/EUR
(0.14%) $0.924

USD/NOK
(-0.05%) $10.53

USD/GBP
(0.24%) $0.787

USD/RUB
(-0.19%) $90.09

Realtime updates for Theranexus SA [ALTHX.PA]

Exchange: EURONEXT Industry: Biotechnology

Last Updated31 May 2024 @ 03:24

25% discount on Stockinvest.us - Use code: Podcast

1.96% € 1.040

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 03:24):

Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders...

Stats
Today's Volume	7 144.00
Average Volume	34 714.00
Market Cap	7.99M
EPS	€0 ( 2024-04-29 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-1.200
ATR14	€0.0120 (1.15%)

Theranexus SA Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Theranexus SA Financials

Annual	2023
Revenue:	€319 000
Gross Profit:	€62 737.00 (19.67 %)
EPS:	€-0.890

FY	2023
Revenue:	€319 000
Gross Profit:	€62 737.00 (19.67 %)
EPS:	€-0.890

FY	2022
Revenue:	€414 898
Gross Profit:	€82 898.00 (19.98 %)
EPS:	€-1.240

FY	2021
Revenue:	€0.00
Gross Profit:	€-5.55M (0.00 %)
EPS:	€-1.622

Financial Reports:

No articles found.

Theranexus SA Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Theranexus SA

Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.